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Abstract The epidemiologic pictures of Kawasaki dis-
ease (KD) in Jilin Province of China is still not clear. We
sent a questionnaire form and diagnostic guidelines for KD
to the province’s 32 hospitals above the county and city
level with pediatric in-patients. All patients with KD diag-
nosed during January 1999 through December 2008 were
recruited in this survey. The incidence of KD was 1.39 to
11.07 (5.26 ± 3.97) per 100,000 children under the age of 5
years between 1999 and 2008. The ratio of male to female
was 1.96 to 1. Ages at onset ranged from 58 days to 14
years. Patients under 5 years of age accounted of 88.73%.
The disease occurred throughout the year, but it occurred
more frequently in May to July and November. The most
common cardiac abnormality was coronary artery dilatation
(49.5%). Age at onset and hypoalbuminemia (\30 g/l) were
selected for multivariate logistic regression equation. In
conclusion, incidences of KD increased in Jilin Province.
Age and gender distribution shared similarities with previ-
ous reports, and the seasonal distribution was different. Age
and lower serum albumin were the most important risk
factors of coronary arterial lesions (CAL) in KD. In addi-
tion, patients treated with steroids also had a possible
heightened risk of contracting CAL.
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Kawasaki disease (KD), or mucocutaneuous lymph node
syndrome, was ﬁrst reported by Dr. Tomisaku Kawasaki of
Japan in 1967. Currently, KD is known to have a world-
wide distribution as a common disease predominantly
affecting children younger than 5 years. Kawasaki disease
is the most common cause of multisystem vasculitis in
children. The vessels most commonly damaged are the
coronary arteries, making KD the number one cause of
acquired heart disease in childhood. Therefore, KD has
become an important research topic in the ﬁeld of pediatric
cardiology. An epidemiologic survey of children hospital-
ized with KD across Jilin Province was conducted. This
survey aimed to understand the incidence and epidemiol-
ogic features of KD, to explore its causes and impact
factors, and to provide a scientiﬁc basis for early diagnosis
and treatment. The results are reported in the following
sections.
Methods
Case Ascertainment and Quality Control
Sets including a survey questionnaire form and diagnostic
guidelines for KD were sent to 32 hospitals above the
county and city level with pediatric in-patients in Jilin
Province, China. Patients with KD were identiﬁed by the
discharge diagnosis code in the records. Pediatricians were
asked to review the medical records and report all patients
with KD during the 10-year span from 1 January 1999
through 31 December 2008.
Training and preparation for the survey were based on
the network of the KD research group established in nine
districts of Jilin Province. All the pediatricians who par-
ticipated in the survey were pediatric cardiologists or
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nated to ensure investigators’ compliance with the study
protocol. Additionally, after all survey questionnaires were
initially collected, the forms were further veriﬁed by two
senior cardiologists in our Pediatric Institute to prevent
anomalies and human error. This collected information
then was pooled into a larger KD database.
Deﬁnition and Recruitment Criteria
The ﬁfth revised edition of diagnostic criteria for KD
issued by the Japan Kawasaki Disease Research Committee
at the 7th International Kawasaki Disease Symposium in
2002 was adopted. Cases were included in the survey if the
patients had at least ﬁve of the following six clinical
manifestations or at least four signs together with coronary
abnormalities documented by echocardiography or coro-
nary angiography: (1) fever persisting 5 days or longer
(including cases with fever that subsided before day 5 in
response to therapy), (2) bilateral conjunctival congestion,
(3) changes in the lips and the oral cavity such as reddening
of lips, strawberry tongue, and diffuse congestion of oral
and pharyngeal mucosa, (4) polymorphous exanthema, (5)
changes in the peripheral extremities such as reddening of
the palms and soles, indurative edema at the initial stage, or
membranous desquamation from the ﬁngertips at the con-
valescent stage; and (6) acute nonpurulent cervical
lymphadenopathy.
In addition, the cases of incomplete KD, diagnosed with
reference to the guidelines for incomplete KD made by the
American Academy of Pediatrics (AAP) and the American
Heart Association (AHA) in 2004 also were included in
this investigation. Patients who did not fulﬁll the afore-
mentioned criteria or who were not in Jilin Province long
enough also were excluded.
Survey Implementation
Basic patient information was recorded on the questionnaire
form. This information included age, gender, ethnic back-
ground and location, date of KD onset, date of diagnosis,
days from onset to hospital visit, clinical signs and symp-
toms, cardiac and extracardiac manifestations, laboratory
examination, echocardiogram (echo) results, prognosis and
treatment, outcome, cardiac sequelae, and recurrence.
Analysis of Risk Factors for Coronary Artery Lesions
The potential risk factors for coronary artery lesion (CAL)
were analyzed including age at onset, sex, month at onset,
fever lasting 10 days or longer, C-reactive protein
([30 mg/l), erythrocyte sedimentation rate (C40 mm/h),
alanine aminotransferase (C40 U/l), white blood cell count
(C12 9 10
9/l), hemoglobin (\90 g/l), blood platelet count
(C450 9 10
9/l), creatine kinase (C25 U/l), serum albumin
level (\30 g/l), and administration of steroids for KD.
Statistical Analysis
Parametric data are expressed as mean ± standard devia-
tion. Nonparametric analysis was performed using the
Pearson chi-square test. Differences in means were com-
pared by t test or one-way analysis of variance (ANOVA).
Logistic regression analysis was performed to analyze the
risk factors for CAL. The partial regression coefﬁcient (B),
standardized partial regression coefﬁcient (SE), odds ratio
(OR), and 95% conﬁdence interval (95% CI) were repor-
ted. A P value less than 0.05 was considered statistically
signiﬁcant. All analyses were performed using IBM SPSS
statistics 18 (IBM, New York, United States).
Results
Response to the Survey
Thesurveyformswerereturnedatarateof93.75%.Fromthe
32 hospitals in 9 districts, 603 KD cases were reported.
During the censorship and quality control, 26 cases were
excluded because they did not fulﬁll the aforementioned
criteria.Theremaining577casesofKDwereenrolledinour
studypopulation.Ofthe577cases,480(83.2%)weretypical
KD according to the ﬁfth revised edition of diagnostic cri-
teria for KD, and the remaining 97 cases (16.8%) were
incomplete KD according to the guidelines for incomplete
KD formulated by AAP and AHA. Furthermore, 512 of the
patients (88.7%) were younger than 5 years, and the
remaining 65 patients were older than 5 years.
Incidence of KD
The incidence rates for KD diagnoses varied signiﬁcantly
from 1999 through 2008. Based on the Statistical Yearbook
data for Jilin Province, the average annual incidence of
diagnosed KD tended to increase by years (Table 1). The
577 patients consisted of 382 (66.2%) males and 195
(33.8%) females, giving a gender ratio of 1.96:1. Four
minority groups were represented by 50 cases (8.7%)
including 43 Korean cases, 4 Manchu cases, 2 Hui cases,
and 1 Mongolian case. These groups were dispersed
throughout the surveyed population.
Age Distribution at Onset of KD
The age at onset of KD, derived from the date of the ﬁrst
diagnosis minus the date of birth, ranged from 58 days to
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12314 years (mean, 2.67 ± 2.37 years). The patients younger
than 1 year accounted for 225 cases (39%), and the patients
younger than 5 years accounted for 512 cases (88.7%). One
incidence peak occurred at the age of 1 year. The distri-
bution of ages at KD onset is shown in Fig. 1.
Seasonal Distribution of KD
As shown in Fig. 2, during the 10-year period, the onset of
KD occurred more frequently from May (62 cases, 10.7%)
to July (66 cases, 11.4%) and November (70 cases, 12.1%),
whereas it occurred relatively less frequently in February
(21 cases, 3.6%). One peak occurred for the boys in June
(48 cases, 8.3%), whereas the peak for the girls occurred in
November (30 cases, 5.2%).
Clinical Manifestations of KD
Among the main clinical manifestations mentioned in the
diagnostic criteria for KD, the most frequent was fever
persisting for 5 days or longer (574 cases, 99.5%), fol-
lowed by changes in the lips and the oral cavity (523 cases,
90.6%), changes in peripheral extremities at the initial
stage or the convalescent stage (490 cases, 84.8%), bilat-
eral conjunctival congestion (439 cases, 76.1%), poly-
morphous exanthema (438 cases, 75.9%), and acute
nonpurulent cervical lymphadenopathy (400 cases, 69.3%).
Additional manifestations included crissum desquamate
(200 cases, 32.9%) and erythema (10 cases, 1.7%) at the
Calmette-Gue ´rin Bacillus inoculation site. The other sys-
tems involved included the respiratory system (325 cases,
Table 1 Incidence of Kawasaki disease (KD) in Jilin Province China from 1999 through 2008 (per 100,000 children younger than 5 years)
Calendar year Males Females Total
No. of
KD
cases
Population KD annual
incidence per
100,000 year
No. of
KD
cases
Population KD annual
incidence per
100,000 year
No. of
KD
cases
Population KD annual
incidence per
100,000 year
1999 12 676,185 1.77 6 614,714 0.98 18 1,290,900 1.39
2000 7 673,776 1.04 5 612,523 0.82 12 1,286,300 0.93
2001 18 660,628 2.72 9 600,571 1.50 27 1,261,200 2.14
2002 19 642,661 2.96 9 584,238 1.54 28 1,226,900 2.28
2003 24 610,133 3.93 15 554,666 2.70 39 1,164,800 3.35
2004 35 559,428 6.26 19 508,571 3.74 54 1,068,000 4.87
2005 48 559,428 8.58 23 508,571 4.52 71 1,068,000 6.65
2006 58 546,333 10.62 29 496,666 5.84 87 1,043,000 8.34
2007 80 536,800 14.90 39 488,000 7.99 119 1,024,800 11.61
2008 81 529885 15.29 41 481,714 8.51 122 1,011,600 11.07
Total 382 5,995,257 66.2 195 5,450,234 33.8 577 11,445,500 5.04
Fig. 1 The distribution of age
at onset of Kawasaki disease in
Jilin Provence, China from 1999
through 2008
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12356.3%), the digestive system (142 cases, 24.6%), the
hematologic system (90 cases, 15.6%), the urinary system
(23 cases, 3.9%), and the joints of extremities (15 cases,
2.6%).
The main clinical manifestations of KD were shown in
Table 2. The acute and subacute stages of the disease
caused no fatality. Three patients (0.5%) had a second
onset of the disease in 3 months to 3 years after the ﬁrst
onset. No speciﬁc factors were found to be associated with
recurrence in our survey.
Echocardiographic Findings of KD
Echocardiographic examinations were carried out in 553
cases (95.8%) within 1 month after the onset of KD.
Among these, 350 cases (63.3%) were found to be abnor-
mal, including coronary artery ectasia (274 cases, 49.5%),
coronary artery stenosis (74 cases, 13.4%), coronary artery
aneurysm (2 cases, 0.36%), pericardial effusion (5 cases,
0.9%), left ventricular enlargement (6 cases, 1.1%), left
artery coronary mural thrombus (2 cases, 0.36%), and right
artery coronary mural thrombus (1 case, 0.18%). Different
cardiac abnormities could be found in one patient
simultaneously.
Administration of Intravenous Immunoglobulin
Infusion of intravenous immunoglobulin (IVIG) (human
freeze-dried low-pH intravenous gammaglobulin; Bio-
chemical Product Institute of Ministry of Public Health,
Chengdu, China) was administrated to 512 patients
(88.7%) within 1 month after KD onset. Although most
patients were administered IVIG within 2 weeks after
disease onset, atypical clinical manifestations of the dis-
ease complicated diagnosis. This caused a delay in the
IVIG treatment for some patients. Others were delayed due
to possible economic constraints.
The regimen of 400 mg/kg/day for 5 consecutive days
was used in 230 cases (39.9%), 1,000 mg/kg once in 19
cases (3.3%), 1,000 mg/kg twice in 148 cases (25.7%),
2,000 mg/kg once in 15 cases (2.6%), irregular amount in
99 cases (17.2%), and no response in 1 case (0.2%).
Among these regimens, 400 mg/kg/day for 5 consecutive
days or 1,000 mg/kg twice was adopted most often. No
adverse effect due to the administration of IVIG was found
in the series. The regimens of IVIG administration are
shown in Fig. 3.
Coronary Artery Lesions and Their Risk Factors
Data on cardiac ﬁndings based on echocardiography were
available for 553 patients. Cardiac lesions of KD were the
most frequent at an age younger than 5 years (90.1%), with
the peak at 1 year, accounting for 45.2% of the patients
younger than 1 year. Signiﬁcant differences were found
between younger and older children, with CAL seen more
frequently in younger children (age, 2.7 ± 2.4 years;
Fig. 2 The seasonal
distribution of Kawasaki disease
in Jilin Provence, China from
1999 through 2008
Table 2 The main clinical manifestations of the 577 patients with
Kawasaki disease in Jilin Provence, China from 1999 through 2008
Clinical symptoms Cases %
Fever 574 99.5
Oral and lip changes 523 90.6
Extremities desquamate 490 84.8
Bilateral conjunctival congestion 439 76.1
Rashes 438 75.9
Lymphadenopathy 400 69.3
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123t = 19.872; P = 0.000). Comparison of incomplete KD
with complete KD showed signiﬁcant differences in the
occurrence of CAL, with an increased frequency in cases
of incomplete KD (49.5% [46/93] vs 66.1% [304/460];
v
2 = 9.202; P\0.05). As to the proportion of CAL, no
signiﬁcant differences were found between the boys and
the girls (61.3% [225/367] vs 67.2% [125/186];
v
2 = 1.847; P[0.05).
Our data showed signiﬁcant differences between the KD
group that had administration of IVIG in CAL as diagnosed
by echocardiography and the group that did not (t =
-18.570; P = 0.000). In our study, 2.4% of the patients
had cardiac sequelae. The most important cardiac sequela
was coronary artery ectasia, which accounted for 78.6% of
the cases, followed by coronary artery aneurysm (14.3%)
and coronary artery stenosis (7.1%). The proportion of
cardiac sequelae was higher among the infants, with 50%
occurring among infants younger than 1 year.
Single-factor analysis of the factors relevant to CAL was
conductedwithafocusonpatientage,sex,monthcontracted,
duration of fever (C10 days), white blood cell count
(C12 9 10
9/l), hemoglobin (\90 g/l), blood platelet count
(C450 9 10
9/l), erythrocyte sedimentation rate (C40 mm/
h), C-reactive protein ([30 mg/l), alanine aminotransferase
(C40 U/l), creatine kinase (CK-MB) (C25 U/l), and serum
albumin (\30 g/l). The results indicated that age at onset
and lower serum albumin were associated with CAL.
Although P values approximating 0.05 for fever persisting
days for 10 days or longer and blood platelet count of
450 9 10
9/l or more may have been relevant to CAL, no
signiﬁcant differences were found. The single-factor analy-
sis of the factors relevant to CAL is shown in Table 3.
We conducted nonconditional multivariate logistic
regression analysis for a single factor that related to
CAL in KD. The results showed that age at onset and
hypoalbuminemia (\30 g/l) were selected for the multi-
variate logistic regression equation, indicating that age at
onset and hypoalbuminemia were risk factors for KD
complicated by CAL (Table 4). We obtained the following
regression equation:
y ¼  0:118X1 þ 0:459X2   1:646:
The ﬁndings showed that administration of steroids was
related to CAL. According to our data, in addition to 13
cases for which it was not clear whether steroids were
administrated before other treatment, the relation between
the incidence of CAL and the administration of steroids
was studied in the remaining 520 patients. The results
showed signiﬁcant differences, with the CAL incidence
signiﬁcantly higher among the patients with steroids than
among the other patients (18.8% [64/341] vs 8.9% [16/
179]; v
2 = 8.71; P\0.005).
Fig. 3 The dosage of
Intravenous immunoglobulin for
Kawasaki disease by calendar
year in Jilin Province, China
from 1999 through 2008
Table 3 Single-factor analysis of the relevant factors for coronary
artery lesion (CAL) among the 553 patients with Kawasaki disease in
Jilin Province, China from 1999 through 2008
Observed indicator v
2 P value
Age 11.474 0.001
a
Sex 1.631 0.202
Incidence for the month 1.697 0.193
Fever persisting C10 days 3.557 0.059
White blood cell count C12 9 10
9/l 0.829 0.363
Hemoglobin\90 g/l 1.332 0.248
Blood platelet count C450 9 10
9/l 3.229 0.072
Erythrocyte sedimentation rate C40 mm/h 2.262 0.133
C-reactive protein[30 mg/l 0.015 0.903
Alanine aminotransferase C40 U/l 0.963 0.326
Creatine kinase C25 U/l 0.321 0.571
Hypoalbuminemia\30 g/l 7.037 0.008
a
a P\0.05. Observed indicators were associated with CAL
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123Discussion
Because the causes of KD are unclear, it is helpful to
conduct a large-scale epidemiologic survey. It is possible to
ﬁnd clues about the etiology and pathogenesis of the dis-
ease [15]. The scientiﬁc literature on KD since 2000 has
been revised and shows that KD has been reported for more
than 60 countries since 2004. The incidence rates are
highest in Japan, followed by the East Asian countries
surrounding Japan such as China, Hong Kong, Taiwan, and
Korea. Meanwhile, the incidence rates (or at least the
diagnostic rates) are increasing in many countries [26].
The incidence of KD has been increasing in the Jilin
Provence of China. Based on the 10-year surveys from
1999 to 2008 in Jilin Provence, the incidence of KD
increased from 1.39 per 100,000 children to 11.07 per
100,000 children younger than 5 years from 1999 to 2008,
which is much lower than the incidence reported in Japan
[17]. Moreover, the incidence of KD in our study also is
much lower than that in Beijing, Shanghai, Sichuan Prov-
ince, Hong Kong, and Taiwan, other developed areas with
large population in China [5, 10, 11, 14, 19, 25]. These data
together indicate that the incidence of KD among Chinese
children has been signiﬁcantly lower than among Japanese
children [17] if these results are truly representative.
The increasing trend also has been found in many other
countries and areas such as Thailand, Korea, England, the
United States, and Hawaii [6–9, 21]. Thus, the reported
incidence of KD is showing a rising trend throughout the
world. However, the true incidence of KD is unknown
because no deﬁnite way to diagnose KD exists. The
reported incidence might be increasing because of
increased awareness rather than a real increase in the dis-
ease. It is worth mentioning that the incidence of KD in
Jilin Provence is similar to that in Israel [3] and Chandigarh
of North India [23], which may be caused by a relatively
underdeveloped economy or other social reasons in these
areas.
Similar to most reports, the age distribution of patients
at onset of KD in our survey predominantly involved
children younger than 5 years. This age group accounted
for 88.73% of the KD cases [5, 10, 14, 25]. Our results are
slightly different from those reported previously in the
nation but consistent with the results reported in Japan
[16].The peak age of KD onset was 1 year, which is similar
to the onset age in Beijing [5].
Male preponderance also was seen in our series. The
male-to-female ratio was 1.96:1, which is slightly higher
than previously reported for most provinces in our country
[5, 10, 14, 25].
According to our data, the disease occurred throughout
the year, as expressed by a double-peak curve. It occurred
more frequently from May to July and November and the
least often in February. However, the seasonal distribution
of KD occurrence varied from country to country and even
from region to region. The onset of KD occurred more
frequently in the summer and spring in Shanghai, Beijing,
and Hong Kong [5, 10, 19, 25]. The patient numbers
peaked from March to May, and the fewest KD cases
occurred during September in the Sichuan province of
China [14]. In Taiwan, KD occurred most frequently in the
summer and least frequently in the winter [11]. Although
the number was highest during the winter months, smaller
increases also occurred during the summer months in Japan
[17].
In the United States, the number of KD patients was
highest in the winter [4]. In Korea, the highest incidence of
KD was seen in June, followed by July and May, similar to
our ﬁrst peak [20]. The reasons for the seasonal discrep-
ancy still remain unclear. We speculate that it may be
related to climatic conditions, geographic environment,
living habits, and the like.
The sequence of main clinical manifestations of KD in
Jilin province was similar to that in previous national
reports [5, 10, 11, 14, 19, 25]. Fever persisting 5 days or
longer was the most frequent clinical manifestation of KD,
Table 4 Nonconditional multivariate logistic regression analysis of Kawasaki disease (KD) complicated by coronary artery lesion (CAL) among
the 553 patients with Kawasaki disease in Jilin Province, China from 1999 through 2008
Observed indicator B SE Wald v
2 P value OR 95% CI for EXP (B)
Lower Upper
Age at onset (X1) -0.118 0.037 9.999 0.002
a 1.125 1.046 1.211
Hypoalbuminemia (\30 g/l) (X2) 0.459 0.196 5.523 0.019
a 1.583 1.079 2.322
CAL -1.646 0.352 21.844 0.000 0.193
B partial regression coefﬁcient, SE standardized partial regression coefﬁcient, OR odds ratio, CI conﬁdence interval, EXP exponent with the
natural logarithm as base, X1o rX2 stand for the variable
a P\0.05, indicated to be statistically signiﬁcant
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123followed by changes in the lips and the oral cavity, changes
in peripheral extremities, bilateral conjunctival congestion,
rashes, and acute nonpurulent cervical lymphadenopathy.
Although not included in the diagnostic criteria of KD,
perianal desquamation was seen in 32.9% of the cases as
well as erythema at the Calmette-Gue ´rin Bacillus inocu-
lation site (1.7%).
As a systemic vasculitis, KD affects multiple systems.
The respiratory system is the most commonly involved
system, followed by the digestive system. Involvement can
be seen in hematologic system, the urinary system, joints of
extremities, and so forth. We found the peak time until
medical attention to be 7.58 ± 4.63 days. Within 6 days,
the patients with a KD diagnosis were fewer because early
atypical clinical manifestations of KD sometimes lead to
late medical attention as well as delayed diagnosis and
treatment. Pediatricians should remain cautious in cases
with fever that persists for 5 days or longer.
Coronary artery lesion is of great concern in KD. The
CAL occurrence rate varies in different reports. In our
survey, CAL was detected in 63.3% of 553 cases (49.5%
with ectasia, 13.4% with stenosis, 0.36% with aneurysm)
during the acute stage. The rate was greater than in other
reports [2, 4, 5, 10, 11, 14, 19, 25]. The higher incidence
rate might be due to progress in diagnosing KD, identifying
cardiac lesions, and universally applying echocardiogra-
phy. Fortunately, the proportion of patients with cardiac
sequelae has decreased year by year [17]. This improve-
ment might have been caused by IVIG therapy. It was
similar to that reported previously for major cardiovascular
complications, with no deaths recorded during the acute
stage in China [5, 10, 11, 14, 19, 25].
Regarding risk factors of CAL in the patients with KD,
this survey found that age and lower serum albumin were
the most important risk factors of CAL in KD: the younger
the age at onset, the higher the risk of CAL and the higher
the incidence of cardiac sequelae. Probably because of
delay in diagnosis, only 41% of infants younger than
6 months were treated with IVIG. Only 14% of these
infants received the therapy during the ﬁrst 10 days of the
disease [22]. Delayed treatment also may have contributed
to the development of cardiac sequelae.
Although an early study by Kato et al. [12] suggested
that steroids exert a detrimental effect when used as the
initial therapy for KD, subsequent studies have shown
either no negative effects or a possible beneﬁt. Arguments
still exist for the use of steroids. Recent reports by Ganesh
et al. [1] have suggested that corticosteroids used in regi-
mens for the initial treatment of KD decreased rates of
retreatment with IVIG. However the addition of cortico-
steroids to standard therapy did not decrease the incidence
of coronary artery aneurysms or adverse events. Tohru
et al. [13] reported that prednisolone with IVIG treatment
was associated with improvement in clinical and coronary
outcomes for patients at high risk for being IVIG nonre-
sponders. In other words, steroids with IVIG in the primary
therapy for KD can relieve symptoms quickly and reduce
the re-application of IVIG but not the probability of CAL
occurrence. It is worth noting that the patients in our data
who received steroid treatment more frequently had CAL.
It is possible that the severely affected children were
treated more readily with steroids, reﬂecting disease
intensity and not some direct effect of steroids themselves
on the development of CAL. Nevertheless, the possible
effects of steroids themselves on the development of CAL
should be not ignored. Careful consideration is required
before steroids are used. The use of steroids should pos-
sibly be considered only for IVIG nonresponders.
In 1991, Newburger et al. [18] reported that the regimen
with 2,000 mg/kg IVIG was better than the divided dose.
Terai and Shulman [24] also reported that the incidence of
coronary artery aneurysm was negatively correlated with
the IVIG dose: the greater the dose of IVIG, the lower the
incidence of CAL. Consequently, IVIG is used more with
the regimen of 1,000 mg/kg once or 1,000 mg/kg twice in
current clinical practice. The reduction in CAL is partly
due to this change. In the survey, for 88.7% of the patients
treated with IVIG therapy, the common dose was 400 mg/
kg for 5 days (39.9%) or 1,000 mg/kg twice (25.7%).
Signiﬁcant differences were proved between the KD
groups with and without administration of IVIG, and CAL
was less frequently seen in patients treated with IVIG.
Simultaneously, the ﬁndings show a signiﬁcant tendency
for an increase in the regimen of 1,000 mg /kg twice since
2003.
The survey had some limitations. Due to the retrospec-
tive nature of the study and the reliance on data from many
different centers, with each center using anticoagulant
drugs different from standard therapy (intravenous immu-
noglobulin ? aspirin) for patients with acute-phase KD,
the treatment effect from every regimen of IVIG could not
be proved. The optimal administrative time and dosage of
IVIG deserve more observations.
In conclusion, the number of KD patients and the KD
incidence rate are increasing year by year in Jilin Provence.
The age and gender distributions are similar to previously
reported data. Seasonal distribution differs from that of
other reports, and onset of KD occurs more frequently from
May to July and November. Age and lower serum albumin
are the most important risk factors of CAL in KD. It is
possible that patients treated with steroids are more sus-
ceptible to CAL.
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